The present invention provides an enantiomerically pure compound of Formula I:
along with pharmaceutical formulations containing the same and methods of use thereof.
Compound of Formula (I) are described: Forumla (I) including pharmaceutically acceptable salts thereof, as well as pharmaceutical formulations or medicaments thereof and the use thereof in the treatment of disorders such as atherosclerosis, multiple sclerosis, psoriasis, and rheumatoid arthritis.